show episodes
 
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
  continue reading
 
Artwork

1
Digital Pathology Podcast

Aleksandra Zuraw, DVM, PhD

Unsubscribe
Unsubscribe
Bulanan+
 
Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.
  continue reading
 
Artwork

1
Deep Pharma Intelligence

Deep Pharma Intelligence

Unsubscribe
Unsubscribe
Harian+
 
Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intell ...
  continue reading
 
Artwork

1
The Future of Pharma

Samir Gondalia, ISPE Boston

Unsubscribe
Unsubscribe
Bulanan
 
The Future of Pharma with ISPE Boston. Find out where the pharmaceutical industry is headed and what it means for you. Join host Samir Gondalia as he chats with the thought leaders of the pharma world about the new technologies, innovative applications and emerging markets and how it’s going to influence the future of Pharma.
  continue reading
 
Discover the transformative power of GenAI, Data Analytics, Social Intelligence, and Physician Influencer Marketing that is shaping the future of pharma marketing. Join us, as we pave the pathway to a novel pharma marketing landscape, bringing to you conversations that meet at the intersection of technology and marketing. Hosted by Saumya Prakash, Co-Founder Multiplier AI Solutions, this podcast is spearheading the dialogues on disruptions in pharma marketing. Know more about us at: https:// ...
  continue reading
 
Intelligent Automation – a powerful confluence of Process Intelligence, Intelligent Document Processing, RPA, Low Code/No Code application development, and Intelligent Virtual Agents, built on a stack of Advanced Intelligence capabilities, powered by Generative AI and supported by Next-gen Infrastructure. It empowers enterprises to drive integrated human experience outcomes, powered by agile configurable workflows.
  continue reading
 
A weekly podcast discussion about asymmetric learning - how organisations gain competitive advantage through their approach to learning, in all its forms. We will talk with thought leaders and experts to understand processes and systems of learning that lead to outperformance.
  continue reading
 
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
  continue reading
 
Welcome to 'Controversial as Fuck' with Hollie Wild, where thought leaders and industry changers converge to amplify voices often silenced and tackle the taboo. Each episode delves into the tough discussions surrounding big pharma, mainstream media, social justice movements, and beyond, grilling the sacred cows of our time. This isn't just a podcast—it's a revolution for those who dare to think differently, engage in conversations that drive real change, and inspire resilience across mental, ...
  continue reading
 
Artwork

1
AI50

Hanh Brown

Unsubscribe
Unsubscribe
Mingguan+
 
AI50 navigates the forefront of technology, delving into the nuances of artificial intelligence, especially focusing on Microsoft's Fabric and Azure AI platforms. Each episode illuminates the latest in scientific innovation, with a special lens on how these advancements interface with the aging population. We unravel the complexities of AI and technology's role in society, providing deep insights and thoughtful analysis. Join us as we explore the ever-changing world of technology, unveiling ...
  continue reading
 
Science Will Win is a podcast that takes listeners under the microscope of some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating scie ...
  continue reading
 
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
  continue reading
 
Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com
  continue reading
 
Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more. Hosted on Acast. See acast.com/privacy for more information.
  continue reading
 
Loading …
show series
 
0:00 Intro to The Genetics Podcast 01:00 Welcome to Marco 02:00 The areas Marco focused on during his academic career and what motivated him to found his first company 03:18 How our understanding of ageing has changed over the past two decades and some of the current big questions in ageing biology 06:01 How to get a clearer picture of the ageing p…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. This week's commercialization news includes Dupixent's success in a chronic hives study, Lilly's development of a weekly insulin shot, and BioMarin's plans for growth. The House backs a bill restricting China's role in US …
  continue reading
 
Get ready, legends—this episode of Comment Chaos is all about diving into the fiery feedback from my recent YouTube clips on Christianity, control, and everything in between. I’m reading your comments, tackling the tough questions, and challenging the mainstream narrative head-on. Whether you agreed, disagreed, or had a completely different take, w…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.EPRO, or electronic patient-reported outcomes, is increasingly used in clinical trials to improve data accuracy, patient compliance, and reduce administrative burdens. Swing Therapeutics achieved 98% patient compliance in t…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Candid, a startup, is investing $370 million to prove the worth of bispecifics in autoimmune diseases. Summit's lung cancer drug has shown significant benefits over Keytruda, a popular immunotherapy drug. Relay's breast can…
  continue reading
 
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Multiple Chinese Firms Expand Global Phase III Trials To Japan(邦訳:中国企業、第三相グローバル治験の地域を続々と日本に拡大)」 https://scrip.citeline.com/SC150842/Multiple-Chinese-Firms-Expand-Global-Phase-III-Trials-To-JapanPlaylist: https://soundcloud.com/citeli…
  continue reading
 
호아킨 두아토 존슨앤존슨 대표가 모건스탠리 헬스케어 컨퍼런스에서 발표한 내용입니다.https://scrip.citeline.com/SC150846/JJ-Interested-In-Differentiated-Obesity-AssetsPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniOleh Citeline
  continue reading
 
Get ready for a raw, unfiltered dive into the messy realities of love, relationships, and karmic ties with the amazing Debbie Pask. We’re not holding back in this episode—we’re talking about the shadows we carry in relationships, how affairs happen, and the deep karmic lessons we’re meant to learn along the way. From soul contracts to shadow work, …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The FTC opposes the merger of two Indiana hospitals under a controversial law. New Mountain merges assets to form a payment accuracy firm. A study shows that female, nonrural physicians deliver more telehealth care. Fertili…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 September 2024. In this episode: J&J interested in differentiated obesity assets; Kerendia hits in heart failure; strong HERCULES data keep Sanofi’s MS plans alive; WCLC preview; and Mankind sets eyes on 5x growth.https://scrip.citeline.com/SC150865/Quick…
  continue reading
 
Pink Sheet reporter and editors discuss the potential fallout if the US FDA’s rare pediatric disease priority review voucher program is allowed to sunset on 1 October (:30), as well as an upcoming agency advisory committee meeting on potentially banning compounding of the now withdrawn pre-term birth prevention drug Makena (18:39).More On These Top…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Biopharma company ArsenalBio recently raised $325 million in funding, marking one of the largest biotech funding rounds of the year. This news comes as Biomarin focuses on growth plans centered around their drug for skeleta…
  continue reading
 
My guest today is Dr. Ben Coverdale. Ben is an experienced Global Account Director of Patsnap with a demonstrated history of working in the life sciences and innovation intelligence industries. Patsnap is Powered by advanced AI, where they help IP and R&D teams collaborate and accelerate the entire innovation lifecycle. He has a strong research pro…
  continue reading
 
0:00 Intro to The Genetics Podcast 01:00 Welcome to Martin 01:35 How a particularly large Indian meal resulted in a book about intermittent fasting and the biology of ageing 05:10 The biological mechanisms behind intermittent fasting, and whether it’s been established to extend life expectancy in humans. 10:13 What we know (and what we don’t) about…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Drug distributors McKesson, Cencora, and Cardinal have agreed to a $300 million settlement for their role in the opioid epidemic, adding to the billions they have already agreed to pay. Prime Healthcare has named Sunny Bhat…
  continue reading
 
In this fiery episode of Comment Chaos, I dive headfirst into the heated discussions surrounding my recent take on Christianity, the Bible, and the manipulation of religious teachings. No stone is left unturned as I tackle the pushback, question the mainstream narrative, and challenge the deeply ingrained beliefs that many hold dear. If you're read…
  continue reading
 
In this episode of Pharma Marketing Playbook, we sit down with Atul Suri, Strategic Business Unit Head at Alembic Pharmaceutical Limited. Atul's remarkable journey spans from his distinguished military service to a leading role in the pharmaceutical industry. He shares his unique perspective on leadership, the importance of adaptability, and how AI…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Viral vector manufacturers are facing challenges such as high production expenses, low titers, empty capsids, and limited scalability when producing cell and gene therapies. To overcome these challenges, they are turning t…
  continue reading
 
In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials. Listen now.…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Pfizer announces positive results for COVID-19 vaccinePfizer has recently announced positive results for its COVID-19 vaccine, with an efficacy rate of over 90%. This news is a significant development in the fight agai…
  continue reading
 
Strap in, legends! In this episode, I'm pulling no punches as I dive headfirst into my raw and controversial views on Christianity, the concept of hell, the rapture, and what it all really means. No sacred cows, no holding back—just an unapologetic challenge to the beliefs that shaped many of us. Whether you’re a devout believer or a curious scepti…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Medtronic's chief medical officer of acute care and monitoring has departed for a new role. The FDA has finalized voluntary malfunction summary reporting guidance. Penumbra is laying off 71 people after axing its virtual …
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 August 2024. In this episode: summer ADC dealmaking continues apace; a look at cell therapies in Japan; Pfizer’s new US digital consumer platform; Galapagos’s US point of care CAR-T study; and Novartis partners with Lindy on biologics delivery.https://sc…
  continue reading
 
Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, including a new AI Council within CDER, as well as some of the unanswered questions about AI in drug development.More On These Topics From The Pink Sheet Artificial Intelligence: CDER’s New Council Takes Char…
  continue reading
 
Send us a text Welcome to the 10th edition of the DigiPath Digest. Today, we discuss essential updates including the free availability of my 'Digital Pathology 101' book and the podcast now accessible on YouTube and YouTube Music. We dive deep into the weekly abstract, focusing on advancements such as sex-specific histopathological models for gliom…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Clinical trials often fail to meet their enrollment goals and schedules, leading to significant financial losses. A new playbook offers solutions to address common challenges in clinical trial recruitment, including strateg…
  continue reading
 
In this week’s Digital Health Roundup, Medtech Insight’s Ryan Nelson highlights Click Therapeutics’ FDA-cleared digital therapeutics (DTx) for depression and Sinaptica Therapeutics’ personalized neuromodulation for Alzheimer’s patients. Marion Webb discusses her interview with MindMaze’s John Krakauer on their gaming-focused DTx to help people reco…
  continue reading
 
0:00 Intro to The Genetics Podcast 01:00 Welcome to Tony 02:00 What Tony was expecting going into the role of CEO at UK Biocentre, and how the COVID-19 pandemic changed his plans 03:38 Receiving a phone call from the UK government in March 2020 asking the UK Biocentre to stop all of its projects and focus on sequencing COVID-19 samples 05:12 The UK…
  continue reading
 
In this episode of the "Pharma Marketing Playbook" series, Saumya Prakash interviews Thambu Raj Anthuvan, Senior Vice President at USV Private Limited, to explore the dynamic intersection of data analytics and AI in the pharmaceutical industry. Together, they discuss how these cutting-edge technologies are transforming marketing strategies, from di…
  continue reading
 
In this quick yet fiery episode of Comment Chaos, I dive into the wild world of online comments. From heated debates on religion to the persistence of some passionate commenters, we're dissecting it all. Tune in as I share the most ridiculous, insightful, and downright hilarious comments from my social media platforms. It's a fast-paced ride throug…
  continue reading
 
Send us a Text Message. Today my guest is Danielle Brown, a fellow veterinary pathologist, the General Manager at Charles River Laboratories Reno, Nevada, and a pioneer in the use of image analysis for toxicologic pathology. Together, we explored the ever-evolving role of image analysis in preclinical studies and how it enhances, rather than replac…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A new healthcare AI accelerator program has been launched by Johns Hopkins, CareFirst, and Techstars, offering funding and guidance to startups working on AI tools. Medicare could face increased spending of $34 billion to …
  continue reading
 
Interest in the human gut microbiome and the influence it exerts on a person’s wellbeing, from cognitive health to immunity, has been rapidly increasing in recent years. In this episode of HBW Insight's Over the Counter podcast we speak to Dublin-based food company Kerry Group about a particularly exciting, emerging area of microbiome-based wellnes…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.J&J plans to change how it pays out discounts to 340B-eligible drugs, causing concerns for hospitals and the government. A report by the HHS' Office of Inspector General found that 1 in 4 for-profit nursing homes are not co…
  continue reading
 
In this raw and unapologetic episode, I rip into the uncomfortable truths about anxiety and depression that mainstream narratives won't touch. We're not here for the watered-down, feel-good nonsense—I'm diving deep into the real causes and exposing the lies that keep you stuck. This episode will challenge everything you thought you knew and push yo…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Steward Health is closing two Ohio hospitals and a Pennsylvania facility due to financial reasons, drawing criticism from healthcare workers and unions. McLaren Health Care in Michigan is facing disruptions from a ransomwa…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 August 2024. In this episode: CMS’s price reveal better than expected?; new diabetes risk data for Zepbound; can J&J’s lung cancer combo stand up to Tagrisso?; new recruits for BioMarin leadership; and Glenmark’s shifting revenues.https://scrip.citeline.…
  continue reading
 
Unlock the power of AI in pharma marketing with our latest episode featuring industry veteran Amaninder Singh Dhillon. From his journey as a trainee to a franchise lead at AstraZeneca, Dhillon shares invaluable insights on leveraging AI for personalized HCP engagement. In this episode, we explore: How data digitization forms the backbone of AI-driv…
  continue reading
 
Send us a text In this episode, we celebrate the 100th edition of the Digital Pathology Podcast! Thank you so much for being part of this journey! You are my Digital Pathology Trailblazers and I prepared a Digital Pathology Trailblazer manifesto for us! This is the 9th edition of DigiPath Digest, and we are attracting more and more people to this s…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Leqembi, a new biotech drug, has been approved in the UK, but reimbursement may not follow due to concerns about the cost to the NHS. The FDA defended its med device chief's tenure after ethics concerns were raised. Employe…
  continue reading
 
Following the recent FDA rejection of MDMA therapy for PTSD, Emma and Flora discuss the future role of psychedelics in the treatment of mental health disorders. Content warning: This episode does contain mentions of sexual assault and abuse.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836​Google Podcas…
  continue reading
 
0:00 Intro 2:00 Mike’s career prior to the Million Veteran Program (MVP), how Mike got to work on MVP, and important milestones in the project's evolution 8:30 Future goals for the Million Veteran Program in expanding and diversifying the research cohort 11:00 The roles of various omics in advancing the project's development 14:30 The most meaningf…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Biopharma news on August 21, 2024 saw changes in Biomarin's C-suite, with Greg Friberg and James Sabry taking over R&D and business development. BridgeBio launched GondolaBio for rare disease drug programs, while Regener…
  continue reading
 
In this unapologetic episode of "Comment Chaos," I take on the madness of TikTok censorship, the audacity of social media trolls, and the polarizing debates that light up the internet. From the absurdity of follower counts to the deep-rooted issues of self-authority, this episode is a no-holds-barred exploration of the digital battleground. Tune in…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.J&J has acquired heart failure implant maker V-Wave for up to $1.7 billion, while Medtronic reiterates its unchanged diabetes strategy despite a partnership with Abbott. Histosonics secured $102 million for a noninvasive …
  continue reading
 
Explore the dynamic shift from traditional to digital marketing strategies in the pharmaceutical sector that is being triggered and drive by GenAI. Join us for a fascinating conversation with Dr. Kavita Lamror, a leading expert in real-world evidence and digital transformation at Maxis Clinical Sciences. In this episode, Dr. Kavita delves into how …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.On August 19, 2024, the FDA approved the first at-home syphilis test by NowDiagnostics, providing quick results with just a drop of blood. Dupont acquired Donatelle Plastics for $313 million, while Boston Scientific resub…
  continue reading
 
Dive into an unfiltered conversation with powerhouse Holly Loxton as we explore trauma, healing, and the transformative power of psychedelics. We'll challenge the concept of the patriarchy and dissect its impact on our lives. Prepare for thought-provoking discussions on politics, religion, and the New Age movement, all with a focus on questioning e…
  continue reading
 
Loading …

Panduan Rujukan Pantas

Podcast Teratas